Abstracts
Showing 851 abstracts.
Citation
Margaret McManus, Mohan Somasundaran, Linda Lambrecht, Richard Hudson, Bobbie Graham, Lynne Mofenson, John L. Sullivan, Katherine Luzuriaga , PACTG 356 Investigators. Early combination antiretroviral therapy alters the persistence of HIV-1 proviruses in HIV-infected infants. Presented at: IAS 2014.Conference
IAS 2014
Citation
Anne H Tran, Brookie M Best, Alice Stek, Regis Kreitchmann, Jiajia Wang, David Shapiro, Elizabeth Smith, Lynne Mofenson, Tim R Cressey, Sandra Burchett, Edmund V Capparelli, Mark Mirochnick, IMPAACT P1026s Protocol Team. Pharmacokinetics of Rilpivirine (Edurant) in HIV-Infected Women During Pregnancy and Postpartum. Presented at: California Society of Health Systems Pharmacists (CSHP)Seminar 2014.Conference
California Society of Health Systems Pharmacists (CSHP)Seminar 2014
Citation
M. L. Rizk, L. Du, L. Wenning, C. Bennetto-Hood , E. P. Acosta Merck & Co., Inc. Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV-infected Children 4 weeks to 18 years of Age. Presented at: ICAAC 2014.Conference
ICAAC 2014
Study
P1066
Citation
Genevieve Fouda, Coleen Cunningham, Elizabeth J. McFarland, William Borkowsky, Nicole Yates, Hua-Xin Liao, Barton Haynes, Georgia Tomaras, Sallie Permar. HIV Env vaccination elicits cross-clade, durable anti-V1V2 IgG responses in HIV-exposed infants. Presented at: CROI 2014.Conference
CROI 2014
Citation
Margaret McManus, Mohan Somasundaran, Linda Lambrecht, Richard Hudson, Bobbie Graham, Lynne Mofenson, John L. Sullivan, Katherine Luzuriaga, the PACTG 356 Investigators. Early effective combination antiretroviral therapy alters HIV-1 persistence in HIV-infected infants. Presented at: IAS 2014.Conference
IAS 2014
Citation
Andres F. Camacho-Gonzalez , Miriam C. Chernoff, Paige L. Williams, Ann Chahroudi , James M. Oleske , Rana Chakraborty , Shirley Traite , Murli U. Purswani , Mark J. Abzug , IMPAACT P1074 Study Team. Sexually Transmitted Infections in Youth with Controlled and Uncontrolled HIV. Presented at: CROI 2015; 2015 Feb 25.Conference
CROI 2015
Study
P1074
Citation
Tim R. Cressey, Rohan Hazra, Andrew Wiznia, Marc Foca, Patrick Jean-Philipe, Bobbie Graham, Paula Britto, Vincent J. Carey, Edward P. Acosta, Ram Yogev, the IMPAACT P1058A team. Pharmacokinetics of Unboosted Atazanavir in Adolescents and Young Adults. Presented at: CROI 2015.Conference
CROI 2015
Study
P1058A
Citation
Mark Mirochnick, Brookie Best, Alice Stek, Regis Kreitchmann, Jiajia Wang, David Shapiro, Elizabeth Smith, Lynne Mofenson, Tim Cressey, Edmund V Capparelli. Pharmacokinetics of Rilpivirine in HIV-Infected Women During Pregnancy and Postpartum. Presented at: CROI 2015; 2015 Feb 24.Conference
CROI 2015
Study
P1026S
Citation
Moherndran Archary, Linda Barlow-Mosha, Avy Violari, Jane Lindsey, Lynne Mofenson, Patrick Jean-Philippe, Paul Palumbo on behalf of the P1060 protocol team. Mycobacterium TB Disease in HIV-infected children receiving LPV/r or NVP-based ART. Presented at: CROI 2015; 2015 Feb 25.Conference
CROI 2015
Study
P1060
Citation
Gayatri Mirani, Paige L Williams, Miriam Chernoff, Mark Abzug, Myron Levin, James Oleske, Shirley Traite, George Seage, Rohan Hazra, Russell B. Van Dyke for the IMPAACT P1074 study team. Mortality of HIV-infected Youth in the cART Era. Presented at: CROI 2015; 2015 Feb 25.Conference
CROI 2015
Study
P1074